Veracyte Inc (VCYT)
19.28
-0.20
(-1.00%)
USD |
NASDAQ |
Apr 26, 16:00
19.28
0.00 (0.00%)
After-Hours: 20:00
Veracyte Gross Profit Margin (Quarterly): 70.09% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 70.09% |
September 30, 2023 | 69.36% |
June 30, 2023 | 67.13% |
March 31, 2023 | 68.18% |
December 31, 2022 | 66.59% |
September 30, 2022 | 65.59% |
June 30, 2022 | 65.65% |
March 31, 2022 | 65.02% |
December 31, 2021 | 66.02% |
September 30, 2021 | 64.15% |
June 30, 2021 | 68.29% |
March 31, 2021 | 66.21% |
December 31, 2020 | 67.61% |
September 30, 2020 | 66.68% |
June 30, 2020 | 63.03% |
March 31, 2020 | 60.66% |
December 31, 2019 | 65.96% |
September 30, 2019 | 70.57% |
June 30, 2019 | 70.88% |
March 31, 2019 | 71.17% |
December 31, 2018 | 66.20% |
September 30, 2018 | 64.80% |
June 30, 2018 | 63.76% |
Date | Value |
---|---|
March 31, 2018 | 60.75% |
December 31, 2017 | 60.35% |
September 30, 2017 | 59.08% |
June 30, 2017 | 62.19% |
March 31, 2017 | 61.68% |
December 31, 2016 | 64.32% |
September 30, 2016 | 65.77% |
June 30, 2016 | 57.06% |
March 31, 2016 | 53.66% |
December 31, 2015 | 56.02% |
September 30, 2015 | 54.45% |
June 30, 2015 | 56.84% |
March 31, 2015 | 59.30% |
December 31, 2014 | 60.12% |
September 30, 2014 | 57.63% |
June 30, 2014 | 54.29% |
March 31, 2014 | 51.75% |
December 31, 2013 | 49.24% |
September 30, 2013 | 44.01% |
June 30, 2013 | 36.25% |
March 31, 2013 | 36.75% |
December 31, 2012 | 41.66% |
September 30, 2012 | 38.46% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
60.66%
Minimum
Mar 2020
70.88%
Maximum
Jun 2019
66.72%
Average
66.59%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
Fonar Corp | 42.89% |
XWELL Inc | 11.86% |
ProPhase Labs Inc | -87.34% |
Applied DNA Sciences Inc | 25.93% |
OncoCyte Corp | -37.26% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -6.97% |
Return on Assets | -6.51% |
Return on Invested Capital | -6.97% |
Profit Margin (Quarterly) | -28.81% |
Operating Margin (Quarterly) | -3.03% |
Return on Net Operating Assets | -8.00% |